Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
34,558
datasets available to search
ShareScore release 0.9.0
Dataset results
34,558 results for “therapy”
Single-Dose Gene Replacement Therapy Using for Patients With Spinal Muscular Atrophy Type 1 With One or Two SMN2 Copies
ClinicalTrials.gov study NCT03837184. IPD Sharing: YES. Countries: 3. Publications: 1.
A Placebo-controlled Study of Efficacy & Safety of 2 Trough-ranges of Everolimus as Adjunctive Therapy in Patients With Tuberous Sclerosis Complex (TSC) & Refractory Partial-onset Seizures
ClinicalTrials.gov study NCT01713946. IPD Sharing: YES. Countries: 25. Publications: 3.
Tailoring Maintenance Therapy to Cluster of Differentiation 5 Positive (CD5+) Regulatory B Cell Recovery in ANCA Vasculitis
ClinicalTrials.gov study NCT03906227. IPD Sharing: YES. Countries: 1. Publications: 1.
Study to Compare the Efficacy and Safety of Enzyme Replacement Therapies Avalglucosidase Alfa and Alglucosidase Alfa Administered Every Other Week in Patients With Late-onset Pompe Disease Who Have No
ClinicalTrials.gov study NCT02782741. IPD Sharing: YES. Countries: 25. Publications: 4.
Study of Safety, Efficacy and Tolerability of Secukinumab Versus Placebo, in Combination With SoC Therapy, in Patients With Active Lupus Nephritis
ClinicalTrials.gov study NCT04181762. IPD Sharing: YES. Countries: 34. Publications: 2.
Study of Efficacy and Safety of Buparlisib (BKM120) Plus Paclitaxel Versus Placebo Plus Paclitaxel in Recurrent or Metastatic Head and Neck Cancer Previously Pre-treated With a Platinum Therapy
ClinicalTrials.gov study NCT01852292. IPD Sharing: UNDECIDED. Countries: 18. Publications: 2.
Phase II Lapatinib Plus Nab-Paclitaxel As First And Second Line Therapy In her2+ MBC
ClinicalTrials.gov study NCT00709761. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
Study of TAK-935 as an Adjunctive Therapy in Participants With Developmental and/or Epileptic Encephalopathies
ClinicalTrials.gov study NCT03166215. IPD Sharing: YES. Countries: 1. Publications: 1.
Special Drug Use Surveillance of Vonoprazan for "Maintenance Therapy of Reflux Esophagitis: Long-term Use"
ClinicalTrials.gov study NCT03214081. IPD Sharing: YES. Countries: 1. Publications: 0.
Triple Combination Therapy in High Risk Crohn's Disease (CD)
ClinicalTrials.gov study NCT02764762. IPD Sharing: YES. Countries: 2. Publications: 1.
Evaluation of SAR440340 and as Combination Therapy With Dupilumab in Moderate-to-Severe Asthma Participants
ClinicalTrials.gov study NCT03387852. IPD Sharing: YES. Countries: 8. Publications: 2.
Study of Dupilumab for the Treatment of Patients With Prurigo Nodularis, Inadequately Controlled on Topical Prescription Therapies or When Those Therapies Are Not Advisable (LIBERTY-PN PRIME)
ClinicalTrials.gov study NCT04183335. IPD Sharing: YES. Countries: 8. Publications: 3.
Brief Cognitive Behavioral Therapy for Chronic Pain
ClinicalTrials.gov study NCT03490981. IPD Sharing: YES. Countries: 1. Publications: 0.
Integrating Animal-Assisted Therapy Into Trauma-Focused Cognitive-Behavioral Therapy for Maltreated Youth
ClinicalTrials.gov study NCT03135119. IPD Sharing: YES. Countries: 1. Publications: 1.
Efficacy and Safety of KD025 in Subjects With cGVHD After At Least 2 Prior Lines of Systemic Therapy
ClinicalTrials.gov study NCT03640481. IPD Sharing: YES. Countries: 1. Publications: 4.
SARS-CoV-2 Immune Responses After COVID-19 Therapy and Subsequent Vaccine
ClinicalTrials.gov study NCT04952402. IPD Sharing: YES. Countries: 1. Publications: 0.
Safety and Tolerability of Conversion From Oral, Injectable, or Infusion Disease Modifying Therapies to Dose-titrated Oral Siponimod (Mayzent) in Advancing RMS Patients
ClinicalTrials.gov study NCT03623243. IPD Sharing: YES. Countries: 2. Publications: 1.
Behavioral or Solifenacin Therapy for Urinary Symptoms in Parkinson Disease
ClinicalTrials.gov study NCT03149809. IPD Sharing: YES. Countries: 1. Publications: 1.
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of TAK-935 (OV935) as an Adjunctive Therapy in Pediatric Participants With
ClinicalTrials.gov study NCT03650452. IPD Sharing: YES. Countries: 8. Publications: 1.
A Study Comparing Risankizumab to Placebo in Participants With Active Psoriatic Arthritis Including Those Who Have a History of Inadequate Response or Intolerance to Biologic Therapy(Ies)
ClinicalTrials.gov study NCT03671148. IPD Sharing: YES. Countries: 25. Publications: 9.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.